INHIBITION OF LENS OPACIFICATION DURING THE EARLY STAGES OF CATARACT FORMATION

被引:0
|
作者
HIRAOKA, T
CLARK, JI
机构
[1] UNIV WASHINGTON, SCH MED, DEPT BIOL STRUCT, SEATTLE, WA 98195 USA
[2] UNIV WASHINGTON, SCH MED, DEPT OPHTHALMOL, SEATTLE, WA 98195 USA
[3] DOKKYO UNIV, SCH MED, DEPT OPHTHALMOL, MIBU, TOCHIGI 32102, JAPAN
关键词
ANTICATARACT; CATARACT; LENS; OPACITY; PANTETHINE; SELENITE;
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose. To characterize the time period during cataract formation in which administration of pantethine inhibits lens cell opacification in the selenite model for cataract. Methods. Pantethine was administered to neonatal rat pups at selected time points from -0.5 to 17 hours with respect to injection of selenite at time = 0. The injection dose of pantethine was 820 mg/kg (1.5 mmol/kg) diluted in water at 410 mg/ml concentration. The injection dose of selenite was 3.28 mg/kg (19 mu mol/kg) diluted in saline at 1.8 mg/ml concentration. Opacification was observed using a slit lamp microscope at selected time points over a 14-day period, Cataracts were staged using a classification of opacity from 0 (normal) to 6 (mature). Results. The effect of pantethine was characterized by three different time periods: administration -0.5 to 6 hours with respect to selenite injection provided highly significant protection, P < 0.001; administration 8 hours after selenite provided significant protection, P < 0.005; administration 10 to 17 hours after selenite was not protective. Conclusions. The metabolite pantethine inhibited lens opacification during cataract formation in the selenite model. Even when pantethine was injected several hours after the administration of selenite, opacification was inhibited. Advanced stages of opacification were unresponsive to the administration of pantethine. The inhibitory effect of pantethine was statistically significant when administered during the earliest stage of opacification in the selenite model for cataract.
引用
收藏
页码:2550 / 2555
页数:6
相关论文
共 50 条
  • [31] Oxidation of lens epithelial proteins during selenite cataract formation.
    Kim, YH
    David, LL
    Shearer, TS
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (04) : S452 - S452
  • [32] Posterior Capsule Opacification After Congenital Cataract Extraction With Intraocular Lens Implantation
    Bar-Sela, S. M.
    Har-Noy, N. Birham
    Spierer, A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [33] Research Progress of Drug Prophylaxis for Lens Capsule Opacification after Cataract Surgery
    Zhang, Rong-Pei
    Xie, Zheng-Gao
    JOURNAL OF OPHTHALMOLOGY, 2020, 2020
  • [34] Gene activation during early stages of lens induction in Xenopus
    Zygar, CA
    Cook, TL
    Grainger, RM
    DEVELOPMENT, 1998, 125 (17): : 3509 - 3519
  • [35] Early opacification and subsequent clearing of a MemoryLens intralocular lens
    Dhoot, Dilsher S.
    Flaxel, Christina J.
    JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2007, 33 (04): : 743 - 745
  • [36] Domain Swapping in Crystallin Proteins Can Drive Early Stages of Cataract Formation
    Patluri, Govardhan Reddy
    Mondal, Balaka
    BIOPHYSICAL JOURNAL, 2020, 118 (03) : 59A - 59A
  • [37] LENS SPECTRIN FODRIN AND CATARACT FORMATION
    KILIC, F
    TREVITHICK, JR
    MOLECULAR BIOLOGY OF THE CELL, 1995, 6 : 2161 - 2161
  • [38] Characterization of Periaxin in the lens and cataract formation
    Arora, Deepika
    Xia, Chun-hong
    Zeng, Jing
    Huang, Zoey
    Li, Mei
    Gong, Xiaohua
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [39] In vitro evaluation of new methods to remove lens epithelial cells during cataract surgery to prevent posterior capsule opacification
    Kottler, UB
    Dietrich, T
    Schlötzer-Schrehardt, U
    Blüthner, K
    Kruse, FE
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
  • [40] PARP inhibition counteracts diabetic cataract formation and early retinal changes
    Obrosova, Irina G.
    Xu, Weizheng
    Zhang, Jie
    Kador, Peter F.
    Ali, Tayyeba K.
    Julius, Ulrich
    El-Remessy, Azza B.
    Drel, Viktor R.
    DIABETES, 2008, 57 : A16 - A16